Open access
Open access
Powered by Google Translator Translator

Archives

RIP Hydroxychloroquine? 2 studies show no benefit in early/mild COVID-19

17 Jul, 2020 | 08:59h | UTC

Study 1: Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19: A Randomized Trial – Annals of Internal Medicine

Study 2: Hydroxychloroquine for Early Treatment of Adults with Mild Covid-19: A Randomized-Controlled Trial – Clinical Infectious Diseases

Commentaries: New Covid-19 study, despite flaws, adds to case against hydroxychloroquine – STAT AND Hydroxychloroquine also doesn’t help Covid-19 patients who aren’t hospitalized, new study finds – CNN

 


How deadly is the coronavirus? The true fatality rate is tricky to find, but researchers are getting closer

17 Jul, 2020 | 08:38h | UTC

How deadly is the coronavirus? The true fatality rate is tricky to find, but researchers are getting closer – The Conversation

 


Open letter: challenge trials for COVID-19

17 Jul, 2020 | 08:48h | UTC

Challenge Trials for COVID-19 – 1 Day Sooner

Commentary: Scientists call for volunteers to be infected with the coronavirus to test vaccines – CNBC

 


What happens if Covid-19 symptoms don’t go away? Doctors are trying to figure it out

17 Jul, 2020 | 08:42h | UTC

What happens if Covid-19 symptoms don’t go away? Doctors are trying to figure it out – Vox

 


Social isolation—the other COVID-19 threat in nursing homes

17 Jul, 2020 | 08:36h | UTC

Social Isolation—the Other COVID-19 Threat in Nursing Homes – JAMA

 


Coronavirus: why are some people experiencing long-term fatigue?

17 Jul, 2020 | 08:40h | UTC

Coronavirus: why are some people experiencing long-term fatigue? – The Conversation

 


Systematic review: International guidelines and recommendations for surgery during Covid-19 pandemic

17 Jul, 2020 | 08:34h | UTC

International guidelines and recommendations for surgery during Covid-19 pandemic: A Systematic Review – International Journal of Surgery

 


ASCO Guideline update: Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers

17 Jul, 2020 | 08:28h | UTC

Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update – Journal of Clinical Oncology

 


Review: Risk of SARS-CoV-2 transmission by aerosols, the rational use of masks, and protection of healthcare workers from COVID-19

17 Jul, 2020 | 08:32h | UTC

Risk of SARS-CoV-2 transmission by aerosols, the rational use of masks, and protection of healthcare workers from COVID-19 – Antimicrobial Resistance & Infection Control

 


Randomized trial: nasogastric decompression vs. no decompression after pancreaticoduodenectomy

17 Jul, 2020 | 08:31h | UTC

Nasogastric Decompression vs No Decompression After Pancreaticoduodenectomy: The Randomized Clinical IPOD Trial – JAMA Surgery (free for a limited period)

Editorial: Randomized Clinical Trial of Nasogastric Tube Placement After Pancreaticoduodenectomy

 


Review: Perioperative management of oral glucose-lowering drugs in the patient with Type 2 Diabetes

17 Jul, 2020 | 08:24h | UTC

Perioperative Management of Oral Glucose-lowering Drugs in the Patient with Type 2 Diabetes – Anesthesiology

 


Meta-analysis: Association between prediabetes and risk of all cause mortality and cardiovascular disease

17 Jul, 2020 | 08:26h | UTC

Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis – The BMJ

 


Fri July 17 – 10 Stories of The Day!

17 Jul, 2020 | 09:01h | UTC

 

1 – RIP Hydroxychloroquine? 2 studies show no benefit in early/mild COVID-19

Study 1: Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19: A Randomized Trial – Annals of Internal Medicine

Study 2: Hydroxychloroquine for Early Treatment of Adults with Mild Covid-19: A Randomized-Controlled Trial – Clinical Infectious Diseases

Commentaries: Hydroxychloroquine also doesn’t help Covid-19 patients who aren’t hospitalized, new study finds – CNN AND New Covid-19 study, despite flaws, adds to case against hydroxychloroquine – STAT

 

2 – Palliative care for patients with severe covid-19 – The BMJ

 

3 – How effective does a COVID-19 coronavirus vaccine need to be to stop the pandemic? A new study has answers – The Conversation

Original Study: Vaccine Efficacy Needed for a COVID-19 Coronavirus Vaccine to Prevent or Stop an Epidemic as the Sole Intervention – American Journal of Preventive Medicine

 

4 – Challenge Trials for COVID-19 – 1 Day Sooner

Commentary: Scientists call for volunteers to be infected with the coronavirus to test vaccines – CNBC

 

5 – Coronavirus Drug and Treatment Tracker – The New York Times

 

6 – What happens if Covid-19 symptoms don’t go away? Doctors are trying to figure it out – Vox

 

7 – Coronavirus: why are some people experiencing long-term fatigue? – The Conversation

 

8 – How deadly is the coronavirus? The true fatality rate is tricky to find, but researchers are getting closer – The Conversation

 

9 – Social Isolation—the Other COVID-19 Threat in Nursing Homes – JAMA

 

10 –COVID-19 Updates / 17 July 2020 Edition

17 July 2020 Edition – COVID-19/SARS-CoV-2 Latest Articles, Guidelines, News & Perspectives (several free resources)

 


WHO and UNICEF warn of a decline in vaccinations during COVID-19

16 Jul, 2020 | 08:36h | UTC

WHO and UNICEF warn of a decline in vaccinations during COVID-19 – World Health Organization

Commentary: Officials warn about drop in childhood vaccination due to COVID-19 – CIDRAP

 


[Preprint] RECOVERY trial: effect of hydroxychloroquine in hospitalized patients with COVID-19

16 Jul, 2020 | 08:39h | UTC

Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial – medRxiv

 

Related Commentary on Twitter (Thread – Click for more)

 


Physical distancing interventions and incidence of coronavirus disease 2019: natural experiment in 149 countries

16 Jul, 2020 | 08:34h | UTC

Physical distancing interventions and incidence of coronavirus disease 2019: natural experiment in 149 countries – The BMJ

Editorial: Lockdown-type measures look effective against covid-19

 


Covid-19: an opportunity to reduce unnecessary healthcare

16 Jul, 2020 | 08:29h | UTC

Covid-19: an opportunity to reduce unnecessary healthcare – The BMJ

Commentary: ED volume recoveries are sluggish. That might not be a bad thing – Health Leaders

 

Related Commentary on Twitter

 


Review: SARS‐CoV‐2 infection risk during elective peri‐operative care

16 Jul, 2020 | 08:28h | UTC

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection risk during elective peri‐operative care: a narrative review – Anaesthesia

 


Covid-19: experts criticize claim that remdesivir cuts death rates

16 Jul, 2020 | 08:31h | UTC

Covid-19: Experts criticise claim that remdesivir cuts death rates – The BMJ

 

Related Commentary on Twitter

 


Study: Many heart attack sufferers are not seeking care due to pandemic

16 Jul, 2020 | 08:26h | UTC

COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England – The Lancet

Commentaries: About 5,000 heart attack sufferers in England missed out on lifesaving hospital treatment due to pandemic – University of Oxford AND Thousands missed heart attack treatment during pandemic – University of Leeds AND Expert reaction to paper suggesting 5000 heart attack sufferers in England did not seek treatment due to the COVID-19 pandemic – Science Media Centre

 


Hematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19

16 Jul, 2020 | 08:24h | UTC

Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study – The Lancet Haematology

Commentary: Coagulation disorder in COVID-19 – The Lancet Haematology

 

Related Commentary on Twitter

 


Fertility, mortality, migration, and population scenarios for 195 countries and territories from 2017 to 2100

16 Jul, 2020 | 08:21h | UTC

Fertility, mortality, migration, and population scenarios for 195 countries and territories from 2017 to 2100: a forecasting analysis for the Global Burden of Disease Study – The Lancet

Commentaries: Earth’s Population Will Begin Shrinking Within 50 Years, Scientists Predict – Science Alert AND Fertility rate: ‘Jaw-dropping’ global crash in children being born – BBC AND Seven countries with big (and small) population problems – BBC AND World population in 2100 could be 2 billion below UN forecasts, study suggests – The Guardian AND Global Population Anticipated to Peak in 2064 – Physician’s Briefing AND The future of migration, human populations, and global health in the Anthropocene – The Lancet

 


Case report: intrauterine transmission of Sars-Cov-2 infection in a preterm infant

16 Jul, 2020 | 08:23h | UTC

Intrauterine Transmission of Sars-Cov-2 Infection in a Preterm Infant – The Pediatric Infectious Disease Journal

Commentary: COVID-19 can be transmitted in the womb, reports pediatric infectious disease journal – Wolters Kluwer Health

 


ATS Guideline: Initiating pharmacologic treatment in tobacco-dependent adults

16 Jul, 2020 | 08:20h | UTC

Initiating Pharmacologic Treatment in Tobacco-Dependent Adults. An Official American Thoracic Society Clinical Practice Guideline – American Journal of Respiratory and Critical Care Medicine

Commentary: ATS releases new practice guideline on treating tobacco dependence in adult smokers – News Medical

 


[Abstract Only] Randomized trial: ticagrelor and aspirin vs. aspirin alone in acute ischemic stroke or TIA

16 Jul, 2020 | 08:17h | UTC

Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA – New England Journal of Medicine

Commentaries: Acute Stroke or Transient Ischaemic Attack Treated With Ticagrelor and ASA for Prevention of Stroke and Death – THALES – American College of Cardiology AND Ticagrelor and aspirin taken post stroke may decrease the risk of recurrent stroke – 2 Minute Medicine

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.